SG11202104863RA - Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing the same and uses thereof - Google Patents
Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing the same and uses thereofInfo
- Publication number
- SG11202104863RA SG11202104863RA SG11202104863RA SG11202104863RA SG11202104863RA SG 11202104863R A SG11202104863R A SG 11202104863RA SG 11202104863R A SG11202104863R A SG 11202104863RA SG 11202104863R A SG11202104863R A SG 11202104863RA SG 11202104863R A SG11202104863R A SG 11202104863RA
- Authority
- SG
- Singapore
- Prior art keywords
- same
- manufacturing
- methods
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/499—Spiro-condensed pyrazines or piperazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18205619 | 2018-11-12 | ||
EP18213016 | 2018-12-17 | ||
PCT/EP2019/080903 WO2020099341A1 (en) | 2018-11-12 | 2019-11-11 | Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing the same and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202104863RA true SG11202104863RA (en) | 2021-06-29 |
Family
ID=68610175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202104863RA SG11202104863RA (en) | 2018-11-12 | 2019-11-11 | Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing the same and uses thereof |
Country Status (15)
Country | Link |
---|---|
US (1) | US20230035837A1 (es) |
EP (1) | EP3880675A1 (es) |
JP (1) | JP2022506957A (es) |
KR (1) | KR20210093292A (es) |
CN (1) | CN113272302A (es) |
AU (1) | AU2019380568A1 (es) |
BR (1) | BR112021009106A2 (es) |
CA (1) | CA3119390A1 (es) |
CL (2) | CL2021001244A1 (es) |
IL (1) | IL282950A (es) |
MX (1) | MX2021005535A (es) |
PH (1) | PH12021551058A1 (es) |
SG (1) | SG11202104863RA (es) |
TN (1) | TN2021000092A1 (es) |
WO (1) | WO2020099341A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022187329A1 (en) * | 2021-03-03 | 2022-09-09 | The Board Of Trustees Of The University Of Illinois | Fabi inhibitors for gram-negative pathogens |
CA3223459A1 (en) | 2021-06-23 | 2022-12-29 | Vincent Gerusz | Novel compounds and their use |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6921763B2 (en) | 1999-09-17 | 2005-07-26 | Abbott Laboratories | Pyrazolopyrimidines as therapeutic agents |
UY26380A1 (es) | 1999-10-08 | 2001-04-30 | Smithkline Beecham Corp | Inhibidores de fab i |
DK1560584T3 (da) | 2001-04-06 | 2009-05-18 | Affinium Pharm Inc | Fab I inhibitorer |
EP1828167B1 (en) | 2004-06-04 | 2014-08-06 | Debiopharm International SA | Acrylamide derivatives as antibiotic agents |
CN101415701A (zh) * | 2005-12-05 | 2009-04-22 | Affinium医药公司 | 作为fabi抑制剂的杂环丙烯酰胺化合物和抗菌剂 |
KR20080075027A (ko) | 2005-12-05 | 2008-08-13 | 아피늄 파마슈티컬스, 인크. | Fabi 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물 |
US7601716B2 (en) | 2006-05-01 | 2009-10-13 | Cephalon, Inc. | Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors |
WO2008009122A1 (en) | 2006-07-20 | 2008-01-24 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as fab i inhibitors |
EP2125802A4 (en) | 2007-02-16 | 2014-08-20 | Debiopharm Int Sa | SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS |
JO3611B1 (ar) * | 2011-08-10 | 2020-08-27 | Janssen Sciences Ireland Uc | سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم |
WO2013042035A1 (en) | 2011-09-19 | 2013-03-28 | Vitas Pharma Research Private Limited | Heterocyclic compounds as inhibitors of fatty acid biosynthesis for bacterial infections |
SG11201402409UA (en) | 2011-12-02 | 2014-10-30 | Aurigene Discovery Tech Ltd | Substituted pyridine derivatives as fabi inhibitors |
EA028136B1 (ru) | 2012-06-19 | 2017-10-31 | Дибиофарм Интернешнл Са | Пролекарственные производные (е)-n-метил-n-((3-метилбензофуран-2-ил)метил)-3-(7-оксо-5,6,7,8-тетрагидро-1,8-нафтиридин-3-ил)акриламида |
US9315522B2 (en) | 2012-08-10 | 2016-04-19 | Janssen Sciences Ireland Uc | Antibacterial compounds |
RS60934B1 (sr) | 2013-09-30 | 2020-11-30 | Guangzhou Innocare Pharma Tech Co Ltd | Supstituisani nikotinimidni inhibitori btk i njihova priprema i upotreba u lečenju karcinoma, inflamatorne i autoimune bolesti |
-
2019
- 2019-11-11 AU AU2019380568A patent/AU2019380568A1/en active Pending
- 2019-11-11 EP EP19805569.1A patent/EP3880675A1/en active Pending
- 2019-11-11 JP JP2021525117A patent/JP2022506957A/ja active Pending
- 2019-11-11 CA CA3119390A patent/CA3119390A1/en active Pending
- 2019-11-11 WO PCT/EP2019/080903 patent/WO2020099341A1/en active Application Filing
- 2019-11-11 US US17/292,600 patent/US20230035837A1/en active Pending
- 2019-11-11 CN CN201980088149.0A patent/CN113272302A/zh active Pending
- 2019-11-11 KR KR1020217018050A patent/KR20210093292A/ko active Search and Examination
- 2019-11-11 MX MX2021005535A patent/MX2021005535A/es unknown
- 2019-11-11 TN TNP/2021/000092A patent/TN2021000092A1/en unknown
- 2019-11-11 SG SG11202104863RA patent/SG11202104863RA/en unknown
- 2019-11-11 BR BR112021009106-8A patent/BR112021009106A2/pt unknown
-
2021
- 2021-05-05 IL IL282950A patent/IL282950A/en unknown
- 2021-05-07 PH PH12021551058A patent/PH12021551058A1/en unknown
- 2021-05-12 CL CL2021001244A patent/CL2021001244A1/es unknown
-
2022
- 2022-12-22 CL CL2022003703A patent/CL2022003703A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP3880675A1 (en) | 2021-09-22 |
JP2022506957A (ja) | 2022-01-17 |
CA3119390A1 (en) | 2020-05-22 |
CL2022003703A1 (es) | 2023-06-09 |
IL282950A (en) | 2021-06-30 |
MX2021005535A (es) | 2021-09-08 |
KR20210093292A (ko) | 2021-07-27 |
WO2020099341A1 (en) | 2020-05-22 |
PH12021551058A1 (en) | 2021-11-22 |
BR112021009106A2 (pt) | 2021-08-10 |
US20230035837A1 (en) | 2023-02-02 |
CL2021001244A1 (es) | 2021-11-19 |
TN2021000092A1 (en) | 2023-01-05 |
AU2019380568A1 (en) | 2021-06-17 |
CN113272302A (zh) | 2021-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3835296A4 (en) | KETOAMIDE COMPOUND AND METHOD FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
EP3442973A4 (en) | INNOVATIVE COMPOUNDS AS AUTOTAXIN INHIBITORS AND PHARMACEUTICAL COMPOSITIONS THEREFOR | |
EP3753943A4 (en) | HETEROCYCLIC COMPOUND, ITS APPLICATION AND PHARMACEUTICAL COMPOSITION CONSISTING OF IT | |
EP3466943A4 (en) | DIPHENYLAMINOPYRIMIDINE AND TRIAZINE COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
EP3580208A4 (en) | NOVEL HETEROCYCLIC COMPOUND, THEIR MANUFACTURING PROCESS AND PHARMACEUTICAL COMPOSITION WITH IT | |
EP3415502A4 (en) | SUBSTITUTED HETEROARYL COMPOUND, COMPOSITION CONTAINING THE SAME, AND APPLICATION THEREOF | |
EP3421038A4 (en) | Naphthyridine compound, pharmaceutical composition and use thereof | |
EP3722395A4 (en) | Anti-friction compound and anti-friction compound with the anti-friction compound | |
EP3743060A4 (en) | ANTIBACTERIAL COMPOUNDS, RELATED COMPOSITIONS AND THEIR METHODS OF USE | |
EP3581183A4 (en) | PHARMACEUTICAL COMPOSITION FOR ONCOTHERAPY | |
EP3697791A4 (en) | HETEROCYCLIC COMPOUNDS, COMPOSITIONS INCLUDING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF | |
EP3551619A4 (en) | COMPOSITIONS WITH METHYLPHENIDATE PRODRUGS, METHOD FOR THE PRODUCTION AND USE THEREOF | |
EP3793563A4 (en) | COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS AND METHODS OF USE THEREOF | |
EP3426671A4 (en) | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF INFECTIONS | |
EP3670500A4 (en) | CHEMICAL COMPOUND, PHARMACEUTICAL COMPOSITION OF IT, CORRESPONDING USE AND APPLICATION | |
IL282950A (en) | Antibiotic compounds, methods for their production, pharmaceutical preparations containing them and their uses | |
EP3497077A4 (en) | AMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS OF USE | |
EP3868371A4 (en) | NOVEL PHARMACEUTICAL COMPOSITION | |
EP3845538A4 (en) | DIHYDROIMIDAZOPYRAZINONE COMPOUND, COMPOSITIONS THEREOF, AND USES THEREOF | |
EP3793561A4 (en) | ANTIVIRAL COMPOUNDS AND THEIR COMPOSITION | |
EP3790552A4 (en) | COMBINATION COMPOSITIONS WITH BISFLUORAKYL-1,4-BENZODIAZEPINONE COMPOUNDS AND METHODS OF USE THERE | |
EP3696176A4 (en) | NOVEL PHENYLPYRIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION WITH IT | |
IL276783A (en) | The composition and pharmaceutical compound containing it | |
EP3950677A4 (en) | QUINOLYL CONTAINING COMPOUND AND PHARMACEUTICAL COMPOSITION AND THEIR USE | |
EP3881841A4 (en) | PHARMACEUTICAL COMPOSITION |